OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of new potent anticancer derivatives through simplifying the core structure and modification on their 14- hydroxyl group from oridonin
Junkai Liu, Shaowen Xie, Xiao Shao, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114155-114155
Closed Access | Times Cited: 14
Junkai Liu, Shaowen Xie, Xiao Shao, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114155-114155
Closed Access | Times Cited: 14
Showing 14 citing articles:
Hit-to-Lead Optimization of the Natural Product Oridonin as Novel NLRP3 Inflammasome Inhibitors with Potent Anti-Inflammation Activity
Chen He, Junkai Liu, Junda Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 9406-9430
Closed Access | Times Cited: 6
Chen He, Junkai Liu, Junda Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 9406-9430
Closed Access | Times Cited: 6
Bioinspired synthesis of cucurbalsaminones B and C
Mengqing Zhang, Jingjing Wu
Angewandte Chemie International Edition (2024)
Open Access | Times Cited: 4
Mengqing Zhang, Jingjing Wu
Angewandte Chemie International Edition (2024)
Open Access | Times Cited: 4
Design and synthesis of 6,20-epoxy A-ring modified oridonin derivatives with antitumor activity through extrinsic and mitochondrial pathways
Haonan Li, Xiaogang Luo, Feilong Zhu, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107632-107632
Closed Access | Times Cited: 2
Haonan Li, Xiaogang Luo, Feilong Zhu, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107632-107632
Closed Access | Times Cited: 2
In Vitro Identification of Oridonin hybrids as Potential Anti-TNBC Agents inducing Cell Cycle Arrest and Apoptosis by Regulation of p21, γH2AX and Cleaved PARP
Jinhua Ning, Nini Zhan, Zhanpan Wu, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 11, pp. 3674-3694
Open Access | Times Cited: 1
Jinhua Ning, Nini Zhan, Zhanpan Wu, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 11, pp. 3674-3694
Open Access | Times Cited: 1
H2S-releasing oridonin derivatives with improved antitumor activity by inhibiting the PI3K/AKT pathway
Haonan Li, Qingyinglu Ma, Yufeng Jia, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 115, pp. 117968-117968
Closed Access | Times Cited: 1
Haonan Li, Qingyinglu Ma, Yufeng Jia, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 115, pp. 117968-117968
Closed Access | Times Cited: 1
Extracellular Vesicles and the Inflammasome: An Intricate Network Sustaining Chemoresistance
Letizia Mezzasoma, Ilaria Bellezza, Rita Romani, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Letizia Mezzasoma, Ilaria Bellezza, Rita Romani, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Bioinspired computational design of lankacidin derivatives for improvement in antitumor activity
Ahmed T. Ayoub, Natsumi Nishiura, Aiko Teshima, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 19, pp. 1349-1360
Closed Access | Times Cited: 4
Ahmed T. Ayoub, Natsumi Nishiura, Aiko Teshima, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 19, pp. 1349-1360
Closed Access | Times Cited: 4
Spirolactone-type and enmein-type derivatives as potential anti-cancer agents derived from oridonin
Xiang Ni, Chen He, Yilin Jia, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 72, pp. 116977-116977
Closed Access | Times Cited: 3
Xiang Ni, Chen He, Yilin Jia, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 72, pp. 116977-116977
Closed Access | Times Cited: 3
Light-promoted stereoselective late-stage difunctionalization and anti-tumor activity of oridonin
Qianhui Tang, Yougan Lu, Junying Song, et al.
Fitoterapia (2024) Vol. 177, pp. 106131-106131
Closed Access
Qianhui Tang, Yougan Lu, Junying Song, et al.
Fitoterapia (2024) Vol. 177, pp. 106131-106131
Closed Access
Bioinspired synthesis of cucurbalsaminones B and C
Mengqing Zhang, Jingjing Wu
Angewandte Chemie (2024)
Closed Access
Mengqing Zhang, Jingjing Wu
Angewandte Chemie (2024)
Closed Access
Discovery of a Natural Ent-Kaurene Diterpenoid Oridonin as an E3 Ligase Recruiter for PROTACs
Jie Huang, Xuekun Fu, Fang Qiu, et al.
Journal of the American Chemical Society (2024)
Closed Access
Jie Huang, Xuekun Fu, Fang Qiu, et al.
Journal of the American Chemical Society (2024)
Closed Access
Design, synthesis and biological evaluation of marine naphthoquinone-naphthol derivatives as potential anticancer agents
Yujuan Li, Luyou Yelv, Xiaoqiu Wu, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access
Yujuan Li, Luyou Yelv, Xiaoqiu Wu, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access
Oridonin protects hydrogen peroxide-induced human lens epithelial cell damage by regulating the NLRP3/NF-κB pathway and Nrf2-mediated oxidative stress
Jie Chen, Wei Zeng, Xili Xiao, et al.
Quality Assurance and Safety of Crops & Foods (2023) Vol. 15, Iss. 1, pp. 107-113
Open Access
Jie Chen, Wei Zeng, Xili Xiao, et al.
Quality Assurance and Safety of Crops & Foods (2023) Vol. 15, Iss. 1, pp. 107-113
Open Access
Spiro-Lactone-Type and Enmein-Type Derivatives as Potential Anti-Cancer Agents Derived from Oridonin
Xiang Ni, Chen He, Wu Xiuyuan, et al.
SSRN Electronic Journal (2022)
Closed Access
Xiang Ni, Chen He, Wu Xiuyuan, et al.
SSRN Electronic Journal (2022)
Closed Access
